Picture of AVITA Medical logo

AVH — AVITA Medical News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Avita Medical Inc Expected To Post A Loss Of 47 Cents A Share: Earnings Preview

* AVITA Medical Inc  AVH.AX   is expected to show a rise in
quarterly revenue when it reports  results on May 13 for the
period ending March 31 2024
    * The Valencia California California-based  company is
expected to
report a 5.3% increase in revenue to $11.113 million from $10.55
million a year ago, according to the mean estimate from 6
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for AVITA Medical Inc is for
a
loss of 47 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for AVITA
Medical Inc
is A$4.75​, above​ its last closing price of A$2.70. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -0.41       -0.38      -0.06     Beat    85.3
 Sep. 30 2023  -0.44       -0.41      -0.07     Beat    83.5
 Jan. 1 0001   -0.34       -0.34      -0.08     Beat    75.8​
 Jan. 1 0001   -0.32       -0.33      -0.07     Beat    77.3
 ​​Dec.                    -0.30                        
 31 2022                                                
 Sep. 30 2022              -0.30                        ​
 Jun. 30 2022              -0.32                        
 Mar. 31 2022              -0.34                        
 This summary was machine generated May 10 at 20:02 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on AVITA Medical

See all news